Gilad Oren

CIK 00019293001 companyDOYLESTOWN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001929300

Recent Transactions

21 trades

Purchase
Aprea Therapeutics, Inc.$APRE
Pre-Funded Warrant
2025-12-10$1.17/sh+21,459→ 21,459 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Warrants
2025-12-10+21,459→ 21,459 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2025-04-03$1.80/sh+2,497→ 345,620 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2025-04-03$1.87/sh+3,003→ 343,123 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2025-03-27+6,725→ 340,120 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2025-03-27+26,900→ 26,900 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-10-23$3.92/sh+500→ 333,395 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-10-15$2.90/sh+250→ 332,895 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-10-14$2.59/sh+1,000→ 332,645 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-10-10$2.54/sh+150→ 331,645 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-03-28+6,725→ 331,495 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2024-03-28+26,900→ 26,900 total
Purchase
Aprea Therapeutics, Inc.$APRE
Common Stock
2024-03-13$7.29/sh+2,000→ 324,770 total
Purchase
Aprea Therapeutics, Inc.$APRE
Tranche A Warrant
2024-03-13+1,000→ 1,000 total
Purchase
Aprea Therapeutics, Inc.$APRE
Tranche B Warrant
2024-03-13+1,000→ 1,000 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Options (Right to Buy)
2023-03-09+16,000→ 16,000 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2023-03-09+4,000→ 322,770 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-08-23+6,045,100→ 6,375,414 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series A Non-Voting Convertible Preferred Stock
2022-08-23−604,510→ 0 total
Award
Aprea Therapeutics, Inc.$APRE
Common Stock
2022-07-28+101,300→ 330,314 total
Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2022-07-28+148,700→ 148,700 total

Companies

Aprea Therapeutics, Inc.
Director, President/CEO
$APRE

Recent Filings

Address

3805 OLD EASTON ROAD

DOYLESTOWN, PA, 18902

View on SEC.gov